Conceptus, Inc. to Highlight Expert OB/GYN Committee's Recommendation That Hysteroscopic Sterilization Become "Best Practice" for Female Sterilization at 41st AAGL Global Congress of Minimally Invasive Gynecology

MOUNTAIN VIEW, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective permanent birth control method available1, will highlight the recent recommendation from a distinguished committee of OB/GYN leaders that hysteroscopic sterilization replace tubal ligation as best practice for female sterilization procedures during its participation at the 41st AAGL Global Congress of Minimally Invasive Gynecology in Las Vegas, Nevada, November 6-8, 2012.